{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:46:24Z","timestamp":1768556784398,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.contraception.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T09:04:12Z","timestamp":1463821452000},"page":"216-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review"],"prefix":"10.1016","volume":"94","author":[{"given":"Sharon J.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petrus S.","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.05.004_bb0005","series-title":"Medical Eligibility Criteria for Contraceptive Use: a WHO family planning cornerstone","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.contraception.2016.05.004_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2016.05.004_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2009.10.013","article-title":"Sino-implant (II) \u2014 a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0020","first-page":"172","article-title":"Serum concentrations of levonorgestrel, estradiol and progesterone in women using China-made long-acting levonorgestrel subdermal implant (Sino-implant) during the first year","volume":"13","author":"Zheng","year":"1993","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0025","first-page":"351","article-title":"Changes in serum estradiol, progesterone and levonorgestrel levels in women during five years after insertion of Sino-implant","volume":"16","author":"Zheng","year":"1996","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0030","first-page":"Cd001326","article-title":"Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy","author":"Power","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2016.05.004_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0010-7824(90)90093-B","article-title":"Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids","volume":"42","author":"Stanczyk","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/gye.15.s2.14.20","article-title":"Mechanism of action of levonorgestrel contraceptive implants","volume":"15","author":"Brache","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2016.05.004_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0010-7824(01)00294-3","article-title":"Mechanisms that explain the contraceptive action of progestin implants for women","volume":"65","author":"Croxatto","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0050","series-title":"Sino-implant (II) project","author":"FHI 360","year":"2013"},{"key":"10.1016\/j.contraception.2016.05.004_bb0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0060","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.05.004_bb0065","first-page":"187","article-title":"Non-reproductive health","volume":"63","author":"Post-marketing surveillance of Norplant\u00ae contraceptive implants: II","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence \u2014 study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2016.05.004_bb0075","article-title":"A comparative study on the acceptability of China-made subdermal implants","volume":"7","author":"Zhang","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2016.05.004_bb0080","first-page":"282","article-title":"A multicenter comparative clinical study of two types of Sino-implant","volume":"79","author":"Xing","year":"2002","journal-title":"Chin J Fam Plann"},{"key":"10.1016\/j.contraception.2016.05.004_bb0085","first-page":"539","article-title":"The effects of long-acting contraceptive implants on bones of reproductive women","volume":"6","author":"Shen","year":"1998","journal-title":"Chin J Fam Plann"},{"key":"10.1016\/j.contraception.2016.05.004_bb0090","article-title":"Multicenter clinical study of two Sino-subdermal implants","volume":"5","author":"Qi","year":"2002","journal-title":"Chin J Fam Plann"},{"key":"10.1016\/j.contraception.2016.05.004_bb0095","first-page":"210","article-title":"Effect of three types of subdermal implants on female body weight","volume":"5","author":"Ni","year":"1998","journal-title":"Chin J Fam Plann"},{"key":"10.1016\/j.contraception.2016.05.004_bb0100","first-page":"92","article-title":"The safety of Sino-implant II \u2014 3years clinical observation","volume":"20","author":"Liu","year":"2000","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0105","first-page":"101","article-title":"A multicentre study of CLa implant and Sino-implant: expanded application (two-year follow-up)","volume":"8","author":"Fang","year":"1997","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0110","first-page":"101","article-title":"A multicenter comparative clinical study of Sino-levonorgestrel-releasing implants \u2014 no. I and no. II with Norplant","volume":"15","author":"Fan","year":"2004","journal-title":"J Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0115","article-title":"The effects of three types of long-acting subcutaneous implants on menstrual blood loss","volume":"6","author":"Han","year":"1998","journal-title":"Chin J Fam Plann"},{"key":"10.1016\/j.contraception.2016.05.004_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.contraception.2013.03.006","article-title":"Performance of Sino-implant (II) in routine service delivery in Madagascar","volume":"88","author":"Feldblum","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2013.11.002","article-title":"Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan","volume":"89","author":"Lendvay","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0130","series-title":"Quality evaluation of Sino-implant (II)","author":"FHI 360","year":"2012"},{"key":"10.1016\/j.contraception.2016.05.004_bb0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2015.06.028","article-title":"In-vivo release of levonorgestrel from Sino-implant (II) - an innovative approach to demonstrate long term bioequivalence","volume":"92","author":"Callahan","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0140","first-page":"7","article-title":"Comparison of in vitro release of China-made long-acting subdermal implant and Norplant","volume":"12","author":"Wu","year":"1992","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0145","first-page":"72","article-title":"A six-year observation of clinical application of China-made type II levonorgestrel subdermal implant (Sino-implant)","volume":"2","author":"Zhang","year":"2000","journal-title":"Chin J Fam Plann"},{"key":"10.1016\/j.contraception.2016.05.004_bb0150","first-page":"141","article-title":"Impact of sino-implant containing LNG on serum lipoprotein metabolism and HDL2-C level in Chinese women","volume":"19","author":"Yang","year":"1999","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.contraception.2016.05.004_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.contraception.2014.10.008","article-title":"Sino-implant (II)(R) continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya","volume":"91","author":"Todd","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.004_bb0160","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.contraception.2016.05.004_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amjmed.2012.12.021","article-title":"Prevalence of covert duplicate publications in Budd-Chiari syndrome articles in China: a systematic analysis","volume":"126","author":"Qi","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2016.05.004_bb0170","series-title":"Medical Eligibility Criteria for Contraceptive Use: a WHO family planning cornerstone","author":"World Health Organization","year":"2015"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T08:29:29Z","timestamp":1617438569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0010782416300786"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.05.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}